top of page
REMED square.png

Building a Sustainable and Differentiated

Therapeutic Pipeline from a Platform of

RENALASE Technologies

Providing 1st to market opportunities for hard-to-treat diseases of immuno-inflammation, pain and cancer

CONTACT

Marc F. Pelletier, Ph.D., CEO

marc.f.pelletier@remedtherapeutics.com

bottom of page